[1]彭 勃,李永平,刘海燕,等.早发型子痫前期患者血清ESM1 及LRP1 表达水平及其与病情严重程度的相关性研究[J].现代检验医学杂志,2023,38(03):184-188.[doi:10.3969/j.issn.1671-7414.2023.03.034]
　PENG Bo,LI Yong-ping,LIU Hai-yan,et al.Study on the Expression Levels of Serum ESM1 and LRP1 in Patients with Early Onset Preeclampsia and Their Correlation with the Severity of the Disease[J].Journal of Modern Laboratory Medicine,2023,38(03):184-188.[doi:10.3969/j.issn.1671-7414.2023.03.034]
点击复制

早发型子痫前期患者血清ESM1 及LRP1 表达水平及其与病情严重程度的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年03期
页码:
184-188
栏目:
检验与临床
出版日期:
2023-05-15

文章信息/Info

Title:
Study on the Expression Levels of Serum ESM1 and LRP1 in Patients with Early Onset Preeclampsia and Their Correlation with the Severity of the Disease
文章编号:
1671-7414（2023）03-184-05
作者:
彭 勃1; 李永平1; 刘海燕1; 朱晓红2
（1. 江苏省盐城市妇幼保健院产科，江苏盐城 224000；2. 江苏省盐城市滨海县中医院产科，江苏滨海 224599）
Author(s):
PENG Bo1;  LI Yong-ping1;  LIU Hai-yan1;  ZHU Xiao-hong2
（1. Department of Obstetrics, Jiangsu Yancheng Maternal and Child Health Care Hospital，Jiangsu Yancheng 224000,China; 2. Department of Obstetrics, Yancheng Binhai County Hospital of Traditional Chinese Medicine, Jiangsu Binhai 224599,China）
关键词:
早发型重度子痫前期; 内皮细胞特异性分子-1; 低密度脂蛋白受体相关蛋白-1
分类号:
R714.244；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.03.034
文献标志码:
A
摘要:
目的 探讨早发型子痫前期(early onset pre-eclampsia, EOSP) 患者血清内皮细胞特异性分子-1（endothelial cellspecific molecule-1，ESM1）及低密度脂蛋白受体相关蛋白-1(low-density lipoprotein receptor-related protein-1，LRP1) 水平及与病情严重程度的相关性。方法 选取2019 年2 月～ 2021 年2 月盐城市妇幼保健院218 例早发型子痫前期患者为研究对象（病例组），根据病情分为轻度组（n=117）和重度组（n=101），以同期健康体检的80 例健康孕妇为对照组。比较各组血清ESM1 和LRP1 水平。采用多因素Logistic 回归分析早发型子痫前期病情严重程度的影响因素。绘制受试者工作曲线分析血清ESM1 和LRP1 对早发型重度子痫前期的诊断价值。结果 病例组血清ESM1(323.05±45.17 mmol/L)，LRP1(12.25±0.97 μg/ml) 水平高于对照组（195.20±31.67 mmol/L，6.41±0.84 μg/ml），差异具有统计学意义（t=23.291，47.677，均P<0.05）。重度组患者血清ESM1(672.44±83.61 pg/ml)，血清LRP1(14.52±1.05 μg/ml)、舒张压（113.17±12.24mmHg）、收缩压（165.19±16.63mmHg）、24h 尿蛋白量（2.63±0.45g/24h）、血肌酐（74.47±20.82μmol/L）、血尿素氮（4.32±0.78mmol/L）、血尿酸（339.65±50.13μmol/L）高于轻度组（551.74±72.20 pg/ml，9.63±0.89 μg/ml，92.41±9.29 mmHg，147.25±14.66mmHg，1.42±0.33g/24h，69.64±15.07μmol/L，3.95±0.91mmol/L，303.82±41.71μmol/L），新生儿体质量低于轻度组（2.73±0.62 kg vs 3.20±0.62 kg），差异具有统计学意义（t=1.980 ～37.978，均P<0.05）。病例组患者血清ESM1 及LRP1 水平与舒张压、收缩压、24h 尿蛋白定量、血肌酐、血尿素氮及血尿酸呈正相关(r=0.413 ～ 0.515，均P <0.05)，与胎儿体质量呈负相关(r=-0.563, -0.604，均P <0.05)。高血清ESM1水平（OR=1.217，95%CI：1.036 ～ 1.429）和高血清LRP1 水平（OR=1.486，95%CI：1.056 ～ 2.090）是影响早发型重度子痫前期发生的独立危险因素。血清ESM1 联合LRP1 诊断早发型重度子痫前期的曲线下面积（area under the curve,AUC）0.884(0.853 ～ 0.916) 大于ESM1（AUC=0.749，95%CI ：0.705 ～ 0.792) 和LRP1（AUC=0.760，95%CI：0.712 ～ 0.807)单独诊断(Z=6.752，4.297，均P <0.05)。结论 早发型子痫前期患者血清ESM1 和LRP1 水平升高，二者均与早发型子痫前期疾病严重程度有关，联合检测能提高早发型重度子痫前期的诊断效能。
Abstract:
Objective To investigate the correlation between the level of serum endothelial cell specific molecule-1 (ESM1) and low-density lipoprotein receptor related protein-1 (LRP1) and the severity of early onset preeclampsia(EOSP). Methods 218 cases of early onset preeclampsia in Yancheng Maternal and Child Health Care Hospital from February 2019 to February 2021 were selected as the study subjects (case group), and were divided into mild group (n=117) and severe group (n=101) according to the condition of the disease,80 healthy pregnant women in the same period were taken as the control group. Serum ESM1 and LRP1 levels were compared in each group. Multivariate logistic regression was used to analyze the influencing factors of the severity of EOPS. The working curve of subjects was drawn to analyze the diagnostic value of serum ESM1 and LRP1 in early onset severe preeclampsia. Results Serum ESM1 (323.05 ± 45.17 mmol/L) and LRP1 (12.25 ± 0.97 μ g/ml) in case group was higher than that in the control group（195.20±31.67 mmol/L，6.41±0.84 μg/ml）, and the differences were statistically significant (t=23.291, 47.677, all P<0.05). Serum ESM1 (672.44 ± 83.61 pg/ml), serum LRP1 (14.52 ± 1.05 μ g/ml), diastolic blood pressure（113.17±12.24mmHg）, systolic blood pressure（165.19±16.63mmHg）, 24h urine protein volume（2.63±0.45g/24h）, blood creatinine（74.47±20.82μmol/L）, lood urea nitrogen（4.32±0.78mmol/L） and blood uric acid （339.65±50.13μmol/L）in the severe group were higher than those in the mild group（551.74±72.20 pg/ml, 9.63±0.89 μg/ml, 92.41±9.29 mmHg, 147.25±14.66mmHg, 1.42±0.33g/24h, 69.64±15.07μmol/L, 3.95±0.91mmol/L, 303.82±41.71μmol/L）, while neonatal body mass was lower than that in the mild group（2.73±0.62 kg vs 3.20±0.62 kg）, the differences were statistically significant(t=1.980 ～ 37.978, all P<0.05). Serum ESM1 and LRP1 levels in case group patients were positively correlated with diastolic blood pressure, systolic blood pressure, 24h urine protein quantity, serum creatinine, blood urea nitrogen and blood uric acid (r=0.413 ～ 0.515, all P<0.05), and negatively correlated with fetal body mass (r=-0.563, -0.604，all P<0.05). High serum ESM1 level (OR=1.217, 95% CI: 1.036 ～ 1.429) and high serum LRP1 level (OR=1.486, 95% CI: 1.056 ～ 2.090) were independent risk factors affecting the occurrence of early onset severe preeclampsia. The area under the curve(AUC) of serum ESM1 combined with LRP1 in diagnosing early onset severe preeclampsia was 0.884 (0.853 ～ 0.916)， which was larger than ESM1(AUC=0.749,95%CI: 0.705 ～ 0.792) and LRP1(AUC=0.760,95%CI: 0.712 ～ 0.807) diagnosed alone(Z=6.752，4.297，all P<0.05). Conclusion Serum ESM1 and LRP1 levels in patients with EOSP were elevated, both of which were related to the severity of EOSP，combined detection can improve the diagnostic efficacy of early onset severe preeclampsia.

参考文献/References:

[1] YANG Yingying, LE RAY I, ZHU Jing, et al. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China[J]. JAMA Netw Open,2021, 4(5): e218401.
[2] 危丽华, 张新, 封伟. 子痫前期孕妇血清SOCS3,PP- 13,GATA-3 水平变化及其预测价值研究[J]. 现代检 验医学杂志, 2022, 37(1): 48-51, 87. WEI Lihua, ZHANG Xin, FENG Wei. Changes of serum SOCS3, PP-13 and GATA-3 levels in preeclampsia and their predictive value[J]. Journal of Modern Laboratory Medicine, 2022, 37(1): 48-51, 87.
[3] CUI Yuanbo, GUO Wenna, LI Ya, et al. Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer[J]. Esophagus, 2021, 18(2): 326- 338.
[4] YAN Yun, LUAN Linlin, XU Jieru. Serum expression of ESM-1, HMWA, and AGEs and its relationship with disease severity in patients with gestational hypertension[J]. Computational and Mathematical Methods in Medicine, 2021, 2021: 9545857.
[5] COOPER J M, LATHUILIERE A, MIGLIORINI M,et al. Regulation of tau internalization, degradation,and seeding by LRP1 reveals multiple pathways for tau catabolism[J]. Journal of Biological Chemistry, 2021,296: 100715.
[6] TU Chengcheng, TAO Feng, QIN Ying, et al. Serum proteins differentially expressed in early- and late-onset preeclampsia assessed using iTRAQ proteomics and bioinformatics analyses[J]. Peer J, 2020, 8: e9753.
[7] 中华医学会妇产科学分会妊娠期高血压疾病学组． 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科 杂志, 2015, 50(10): 721-728. Hypertensive Disorders in Pregnancy Subgroup,Chinese Society of Obstetrics and Gynaecology,Chinese Medical Association. Diagnosis and treatment guideline of hypertensive disorders in pregnancy (2015) [J]. Chinese Journal of Obstetrics and Gynecology,2015, 50(10): 721-728.
[8] IVES C W, SINKEY R, RAJAPREYAR I, et al. Preeclampsia-pathophysiology and clinical presentations: JACC State-of-the-Art review[J]. Journal of the American College of Cardiology, 2020, 76(14): 1690-1702.
[9] KUCUKBAS G N, SANHAL C Y, UYGUR D. Plasma endocan levels in early and late-onset preeclampsia[J]. Fetal and Pediatric Pathology, 2021, 40(3): 214-221.
[10] ZHAO Haiyan, WANG Yang, ZHANG Xiaoli, et al. MiR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1[J]. Toxicology and Applied Pharmacology, 2020, 386: 114827.
[11] WATANABE M, HORIE H, KURATA Y , et al. ESM1 and STC1 as angiogenic factors responsible for protective actions of adipose-derived stem cell sheets on chronic heart failure after rat myocardial infarction[J]. Circ J, 2021, 85(5):657-666.
[12] JIN Hana, RUGIRA T, KO Y S, et al. ESM-1 overexpression is involved in increased tumorigenesis of radiotherapy-resistant breast cancer cells[J]. Cancers,2020, 12(6): 1363.
[13] KIM E, YANG J, PARK K W, et al. Inhibition of VEGF signaling reduces diabetes-exacerbated brain swelling,but not infarct size, in large cerebral infarction in mice[J]. Translational Stroke Research, 2018, 9(5): 540-548.
[14] WATANABE M, HORIE H, KURATA Y, et al. ESM1 and STC 1 as agiogenic factors responsible for protective actions of adipose-derived stem cell sheets on chronic heart failure after rat myocardial infarction[J]. Circ J, 2021, 85(5): 657-666.
[15] JUNG E, ROMERO R, YEO L, et al. The etiology of preeclampsia[J]. American Journal of Obstetrics and Gynecology, 2022, 226(2S): S844-S866.
[16] YANG Yu, WANG Yixiao, L? Yan, et al. Dissecting the roles of lipids in preeclampsia[J]. Metabolites, 2022,12(7): 590.
[17] THOMAS C, LELEU D, MASSON D. Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis[J]. Front Immunol, 2022, 13:868958.
[18] TAYLOR M K, SULLIVAN D K, KELLER J E, et al. Potential for ketotherapies as amyloid-regulating treatment in individuals at risk for Alzheimer’s disease[J].Front Neurosci, 2022, 16:899612.
[19] ACTIS DATO V, BENITEZ-AMARO A, DE GONZALO-CALVO D, et al. LRP1-mediated agg LDL endocytosis promotes cholesteryl ester accumulation and impairs insulin response in HL-1 cells[J]. Cells (Basel, Switzerland), 2020, 9(1): 182.
[20] VALENTE V, IZZO R, MANZI M V, e t a l . Modulation of insulin resistance by renin angiotensin system inhibitors: implications for cardiovascular prevention[J]. Monaldi Archives for Chest Disease,2021, 91(2): 1602.
[21] GARC?A-G?MEZ E, BOBADILLA-BRAVO M,D?AZ-D?AZ E, et al. High plasmatic levels of advanced glycation end products are associated with metabolic alterations and insulin resistance in preeclamptic women[J]. Current Molecular Medicine, 2020, 20(9): 751-759.

备注/Memo

备注/Memo:
基金项目：江苏省卫生健康委科研项目（M2020337）：早发型子痫前期患者血清ESM1 及LRP1 表达及两者与病情严重程度的相关性研究。
作者简介：彭勃（1971-），女，本科，主任医师，研究方向：子痫前期，E-mail：pengbo4289@163.com。
通讯作者：朱晓红（1973-），女，硕士研究生，主任医师，研究方向：妊娠综合症，E-mail：zhuxiaohong19730622@163.com。
更新日期/Last Update: 2023-05-15